Matches in SemOpenAlex for { <https://semopenalex.org/work/W2619185438> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2619185438 abstract "Background: The PEGASUS trial demonstrated a reduction in ischemic events following P2Y 12 inhibition with ticagrelor among patients with a prior MI. The implications of these findings for clinical practice are unknown. Methods: We sought to determine the proportion of real-world myocardial infarction (MI) patients who would have been eligible for the PEGASUS-TIMI 54 trial, to characterize their current use of P2Y12 inhibitors, and to explore the estimated costs and ischemic event consequences of increasing P2Y12 inhibitor use among these patients. In the U.S. national ACTION Registry-GWTG, We identified 273,328 MI patients and determined the proportion that would have met the eligibility criteria for the PEGASUS trial. We described longitudinal P2Y 12 inhibitor use among PEGASUS eligible patients and estimated the cost and ischemic consequences of increasing P2Y 12 use among eligible patients. Results: A total of 112,222 (41.1%) MI patients in ACTION Registry-GWTG met eligibility for the PEGASUS trial. Among 83,871 eligible patients with pharmacy claims data, 23,042 (27.5%) were on a P2Y 12 inhibitor at 1 year, 9,661 (11.5%) at 2 years, and 5,246 (6.3%) at 3 years (see Figure), with the majority (79.2%) of these patients on clopidogrel. Use of ticagrelor in eligible patients not already on a P2Y 12 inhibitor at 1-year post MI would cost an estimated $885,000 per myocardial infarction, stroke, or cardiovascular death averted over a 3-year time horizon, while use of clopidogrel would cost an estimated $19,800 per ischemic event averted. Conclusions: In contemporary clinical practice, a minority of patients are on a P2Y 12 inhibitor beyond 1-year post-MI. Applying PEGASUS trial findings to clinical practice would result in a large increase in P2Y 12 inhibitor use with a cost per ischemic event averted that is strongly influenced by the choice of therapy." @default.
- W2619185438 created "2017-06-05" @default.
- W2619185438 creator A5000460998 @default.
- W2619185438 creator A5022656025 @default.
- W2619185438 creator A5033435340 @default.
- W2619185438 creator A5036158005 @default.
- W2619185438 creator A5052836671 @default.
- W2619185438 creator A5060915805 @default.
- W2619185438 creator A5069400507 @default.
- W2619185438 creator A5072347699 @default.
- W2619185438 creator A5073645809 @default.
- W2619185438 date "2017-03-01" @default.
- W2619185438 modified "2023-09-27" @default.
- W2619185438 title "Abstract 211: Implications of the PEGASUS-TIMI 54 Trial for U.S. Clinical Practice" @default.
- W2619185438 doi "https://doi.org/10.1161/circoutcomes.10.suppl_3.211" @default.
- W2619185438 hasPublicationYear "2017" @default.
- W2619185438 type Work @default.
- W2619185438 sameAs 2619185438 @default.
- W2619185438 citedByCount "0" @default.
- W2619185438 crossrefType "journal-article" @default.
- W2619185438 hasAuthorship W2619185438A5000460998 @default.
- W2619185438 hasAuthorship W2619185438A5022656025 @default.
- W2619185438 hasAuthorship W2619185438A5033435340 @default.
- W2619185438 hasAuthorship W2619185438A5036158005 @default.
- W2619185438 hasAuthorship W2619185438A5052836671 @default.
- W2619185438 hasAuthorship W2619185438A5060915805 @default.
- W2619185438 hasAuthorship W2619185438A5069400507 @default.
- W2619185438 hasAuthorship W2619185438A5072347699 @default.
- W2619185438 hasAuthorship W2619185438A5073645809 @default.
- W2619185438 hasConcept C126322002 @default.
- W2619185438 hasConcept C19527891 @default.
- W2619185438 hasConcept C2777995511 @default.
- W2619185438 hasConcept C2779974597 @default.
- W2619185438 hasConcept C2780400711 @default.
- W2619185438 hasConcept C500558357 @default.
- W2619185438 hasConcept C512399662 @default.
- W2619185438 hasConcept C71924100 @default.
- W2619185438 hasConceptScore W2619185438C126322002 @default.
- W2619185438 hasConceptScore W2619185438C19527891 @default.
- W2619185438 hasConceptScore W2619185438C2777995511 @default.
- W2619185438 hasConceptScore W2619185438C2779974597 @default.
- W2619185438 hasConceptScore W2619185438C2780400711 @default.
- W2619185438 hasConceptScore W2619185438C500558357 @default.
- W2619185438 hasConceptScore W2619185438C512399662 @default.
- W2619185438 hasConceptScore W2619185438C71924100 @default.
- W2619185438 hasLocation W26191854381 @default.
- W2619185438 hasOpenAccess W2619185438 @default.
- W2619185438 hasPrimaryLocation W26191854381 @default.
- W2619185438 hasRelatedWork W1639292827 @default.
- W2619185438 hasRelatedWork W185370496 @default.
- W2619185438 hasRelatedWork W1886382183 @default.
- W2619185438 hasRelatedWork W2090078074 @default.
- W2619185438 hasRelatedWork W2093709628 @default.
- W2619185438 hasRelatedWork W2127655789 @default.
- W2619185438 hasRelatedWork W2153087016 @default.
- W2619185438 hasRelatedWork W2332800548 @default.
- W2619185438 hasRelatedWork W2510703886 @default.
- W2619185438 hasRelatedWork W2552600947 @default.
- W2619185438 hasRelatedWork W2782819296 @default.
- W2619185438 hasRelatedWork W2791598509 @default.
- W2619185438 hasRelatedWork W2936797975 @default.
- W2619185438 hasRelatedWork W3013592673 @default.
- W2619185438 hasRelatedWork W3114573885 @default.
- W2619185438 hasRelatedWork W3155558683 @default.
- W2619185438 hasRelatedWork W3191964698 @default.
- W2619185438 hasRelatedWork W2162084532 @default.
- W2619185438 hasRelatedWork W3106058418 @default.
- W2619185438 hasRelatedWork W3206784653 @default.
- W2619185438 isParatext "false" @default.
- W2619185438 isRetracted "false" @default.
- W2619185438 magId "2619185438" @default.
- W2619185438 workType "article" @default.